Achondroplasia Trial Design: US FDA Panel Moves Patient-Centered Development To The Forefront

Advisory committee’s recommendations on secondary endpoints for pivotal studies reflects patient and caregiver comments during the open public hearing about the disease’s clinical complications, including ear infections and sleep apnea, and challenges performing activities of daily living.

FDA Advisory Committee Feature image

More from US FDA Performance Tracker

More from Regulatory Trackers